[Retrospective analysis of nosocomial COVID-19: a comparison between patients with hematological disorders and other diseases].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Japan Society Of Clinical Hematology Country of Publication: Japan NLM ID: 2984782R Publication Model: Print Cited Medium: Print ISSN: 0485-1439 (Print) Linking ISSN: 04851439 NLM ISO Abbreviation: Rinsho Ketsueki Subsets: MEDLINE
    • Publication Information:
      Publication: Tokyo : Japan Society Of Clinical Hematology
      Original Publication: Tokyo, Rinsho Ketsueki Kondankai.
    • Subject Terms:
      Coronavirus Infections/*complications ; Cross Infection/*complications ; Hematologic Diseases/*complications ; Pneumonia, Viral/*complications; Betacoronavirus ; COVID-19 ; Coronavirus Infections/physiopathology ; Cross Infection/virology ; Hematologic Diseases/virology ; Humans ; Pandemics ; Pneumonia, Viral/physiopathology ; Retrospective Studies ; SARS-CoV-2 ; Survival Rate
    • Abstract:
      Nosocomial coronavirus disease 2019 (COVID-19) had occurred at our hospital. We retrospectively analyzed the differences between patients with nosocomial COVID-19 and either hematological disease (n=40) or other diseases (n=57). The analysis was completed within 60 days for surviving patients. Among the patients with hematological disease and those with other diseases, there were 21 (52.5%) and 20 (35.1%) deaths, respectively. Although the patients with hematological disease received favipiravir more frequently than patients with other diseases (21 [52.5%] vs. 15 [35.3%], respectively; P<0.05), their median overall survival was poor (29 days; P=0.078). Furthermore, the median duration from oxygen therapy initiation to death or intubation was significantly shorter in the patients with hematological disease (5 days [range, 1-17 days] vs. 10 days [1-24 days], respectively; P<0.05). Furthermore, the patients with hematological disease and nosocomial COVID-19 exhibited more marked respiratory failure and poorer outcomes leading to death in a shorter time period than the patients with other diseases and nosocomial COVID-19.
    • Contributed Indexing:
      Keywords: COVID-19; Hematological disease; Nosocomial infection
    • Publication Date:
      Date Created: 20200910 Date Completed: 20200915 Latest Revision: 20201218
    • Publication Date:
      20250114
    • Accession Number:
      10.11406/rinketsu.61.857
    • Accession Number:
      32908046